Efficacy and safety after one-year treatment with polymerized allergen immunotherapy mixture; real-world study

被引：0
|
作者：
Feliu Vila, A. [1 ]
Rico Collado, P. [1 ]
Lopez Couso, V. [2 ]
机构：
[1] Hosp Tajo, Aranjuez, Spain
[2] Med Ctr FERMIN CABALLERO, Madrid, Spain
来源：
ALLERGY | 2023年 / 78卷
关键词：
D O I：
暂无
中图分类号：
R392 [医学免疫学];
学科分类号：
100102 ;
摘要：
000466
引用
收藏
页数：1
相关论文
共 50 条
  • [1] One-year clinical efficacy and safety of indigo naturalis for active ulcerative colitis: a real-world prospective study
    Matsuno, Yuichi
    Torisu, Takehiro
    Umeno, Junji
    Shibata, Hiroki
    Hirano, Atsushi
    Fuyuno, Yuta
    Okamoto, Yasuharu
    Fujioka, Shin
    Kawasaki, Keisuke
    Moriyama, Tomohiko
    Nagasue, Tomohiro
    Zeze, Keizo
    Hirakawa, Yoichiro
    Kawatoko, Shinichiro
    Koga, Yutaka
    Oda, Yoshinao
    Esaki, Motohiro
    Kitazono, Takanari
    INTESTINAL RESEARCH, 2022, 20 (02) : 260 - +
  • [2] One-year effectiveness and safety of ustekinumab in ulcerative colitis: a multicenter real-world study from Italy
    Chiappetta, Michele Francesco
    Viola, Anna
    Mastronardi, Mauro
    Turchini, Laura
    Carparelli, Sonia
    Orlando, Adele
    Biscaglia, Giuseppe
    Miranda, Agnese
    Guida, Laura
    Costantino, Giuseppe
    Scaldaferri, Franco
    Bossa, Fabrizio
    Renna, Sara
    Cappello, Maria
    Alibrandi, Angela
    Orlando, Ambrogio
    Armuzzi, Alessandro
    Fries, Walter
    EXPERT OPINION ON BIOLOGICAL THERAPY, 2021, 21 (11) : 1483 - 1489
  • [3] Patients' experience and treatment effectiveness after receiving allergen immunotherapy - A real-world experience
    Yung, Ching Ching
    Jayasundera, Joseph
    Siew, Leonard
    Pillai, Prathap
    CLINICAL AND EXPERIMENTAL ALLERGY, 2022, 52 (08): : 1004 - 1004
  • [4] Real-World Safety and Efficacy Clinical Data of an Improved Allergen-Specific Immunotherapy Product for the Treatment of Bee Venom Allergy
    Gonzalez Guzman, Luis Alfredo
    Garcia Robaina, Jose Carlos
    Barrios Recio, Javier
    Escudero Arias, Elena
    Linares Mata, Tania
    Cervera Aznar, Raquel
    Pinzon, Federico de la Roca
    Polo, Lissette del Carmen Miguel
    Villarroel, Luis Arenas
    Couso, Veronica P. Lopez
    Diaz, Javier Alcover
    Gil, David Rodriguez
    Pelaez, Ricardo Palacios
    Gonzalez, Francisco Javier Carballada
    VACCINES, 2023, 11 (05)
  • [5] One-year evaluation of clinical and immunological efficacy and safety of sublingual versus subcutaneous allergen immunotherapy in allergic conjunctivitis
    Khulood M. Sayed
    Ahmed G. Kamel
    Abdellah H. Ali
    Graefe's Archive for Clinical and Experimental Ophthalmology, 2019, 257 : 1989 - 1996
  • [6] One-year evaluation of clinical and immunological efficacy and safety of sublingual versus subcutaneous allergen immunotherapy in allergic conjunctivitis
    Sayed, Khulood M.
    Kamel, Ahmed G.
    Ali, Abdellah H.
    GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY, 2019, 257 (09) : 1989 - 1996
  • [7] Safety and efficacy of ofatumumab during one-year treatment: a multicentre study
    Pastor, Silvia
    Santos, Laura
    Gonzalez, Carmen
    Gomez, Ana
    Stiauren, Erik
    Martinez Ramos, Juana
    Nieto, Pablo
    MULTIPLE SCLEROSIS JOURNAL, 2024, 30 (03) : 1116 - 1117
  • [8] Efficacy and safety of apatinib in treatment of unresectablehepatocellular carcinoma: A real-world study
    Liu, Jun
    Li, Guangbing
    He, Qiang
    Sun, Shijun
    Zhao, Chuanlin
    Sun, Chuandong
    Zhang, Bo
    Cui, Yi
    Ye, Yongqiang
    Zhi, Xuting
    Li, Shiping
    Pan, Guozheng
    Ma, Changlin
    Hu, Jinhua
    Li, Jun
    Wang, Suling
    Qiao, Yuangang
    Ren, Wanhua
    Meng, Qi
    CANCER RESEARCH, 2022, 82 (12)
  • [9] One-year outcomes of biological mesh in hiatal hernia repair: a real-world study
    Xianggang Huang
    Xiangyu Shao
    Junsheng Li
    Hernia, 29 (1)
  • [10] THE REAL-WORLD EFFICACY OF PEMAFIBRATE ON METABOLIC-ASSOCIATED FATTY LIVER DISEASE (MAFLD): A ONE-YEAR RETROSPECTIVE STUDY
    Katsuyama, H.
    Hakoshima, M.
    Adachi, H.
    Yanai, H.
    ATHEROSCLEROSIS, 2023, 379 : S145 - S145
12345